GlaxoSmithKline to acquire remaining 51% stake in Shenzhen GSK-Neptunus Biologicals - MarketLine Financial Deals

GlaxoSmithKline to acquire remaining 51% stake in Shenzhen GSK-Neptunus Biologicals

GlaxoSmithKline to acquire remaining 51% stake in Shenzhen GSK-Neptunus Biologicals - MarketLine Financial Deals
GlaxoSmithKline to acquire remaining 51% stake in Shenzhen GSK-Neptunus Biologicals
Published Jun 14, 2011
3 pages — Published Jun 14, 2011
Price US$ 20.00  |  Buy this Report Now

About This Report

  
Abstract:

GlaxoSmithKline plc (GSK) has entered into an agreement to acquire the remaining 51% equity interest in Shenzhen GSK-Neptunus Biologicals Co., Ltd. (GSKNB) from Shenzhen Neptunus Interlong Bio-Tech Co., Ltd. (SNIB).

  
Source:
Document ID
MA66972_110617
Country
Country
Country
Ticker
8329=HK
Ticker
GSK=GB
Format:
PDF Adobe Acrobat
Buy Now

MarketLine Financial Deals—MarketLine Financial Deals – Identifying and tracking major financial activity across our full scope of company and sector coverage, MarketLine Financial Deals covers mergers & acquisitions, private equity/venture capital backed buyouts, investments, and exits, IPOs and secondary and follow on offerings, and private placements and exits. Additional non-corporate financial deals including partnership agreements, joint ventures, co-development and research, licensing and co-marketing agreements are also available.

About the Author


Cite this Report

  
MLA:
MarketLine Financial Deals. "GlaxoSmithKline to acquire remaining 51% stake in Shenzhen GSK-Neptunus Biologicals" Jun 14, 2011. Alacra Store. Dec 06, 2016. <http://www.alacrastore.com/storecontent/MarketLine-Financial-Deals/GlaxoSmithKline-to-acquire-remaining-51-stake-in-Shenzhen-GSK-Neptunus-Biologicals-2052-62677>
  
APA:
MarketLine Financial Deals. (2011). GlaxoSmithKline to acquire remaining 51% stake in Shenzhen GSK-Neptunus Biologicals Jun 14, 2011. New York, NY: Alacra Store. Retrieved Dec 06, 2016 from <http://www.alacrastore.com/storecontent/MarketLine-Financial-Deals/GlaxoSmithKline-to-acquire-remaining-51-stake-in-Shenzhen-GSK-Neptunus-Biologicals-2052-62677>
  
US$ 20.00
$  £  
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research

Search all our MarketLine Financial Deals from one place.